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Recent studies have suggested a microenvironmental contribution to stemcell aging, but the mechanisms are largely unexplored. Mé ndez-Ferrer et al. report anatomical remodeling of blood-stemcell-supporting niches and functional switch of b adrenergic signals, leading to myeloid expansion during aging. Targeting the microenvironment can improve pathological, premature, nichedependent hematopoietic aging in mice.
INTRODUCTION
Hematopoietic aging is characterized by expansion of hematopoietic stem cells (HSCs) with impaired function, such as reduced engraftment, quiescence, self-renewal, unfolded protein response, and lymphoid differentiation potential, leading to myeloid-biased output both in mice (Liang et al., 2005; Mohrin et al., 2015; Rossi et al., 2005; Sudo et al., 2000) and humans (Pang et al., 2011; Rundberg Nilsson et al., 2016) . Myeloid malignancies are more frequent in the elderly, but whether changes in the aged HSCs and/or their microenvironment predispose to these malignancies remains unclear. HSC aging was initially considered to result only from intrinsic changes (Dykstra et al., 2011) , such as epigenetic deregulation (Chambers et al., 2007) , replication stress (Flach et al., 2014) , deficient DNA repair (Rossi et al., 2007) , transition from canonical to non-canonical Wnt signaling (Florian et al., 2013) , and increased autophagy (Ho et al., 2017) . However, aging also reduces HSC polarity and capacity to lodge near bone (Kö hler et al., 2009) , and microenvironmental alterations have been proposed to contribute to hematopoietic aging. For instance, myeloid bias can result from telomere dysfunction (Ju et al., 2007) or inflammatory cytokine production (Ergen et al., 2012) in the aged hematopoietic microenvironment, and bone marrow (BM) adrenergic nerve degeneration has been recently proposed to drive HSC aging reversibly (Maryanovich et al., 2018) . However, the relative contribution of intrinsic and extrinsic mechanisms to HSC aging remains debated. Myeloid-biased HSCs (Gekas and Graf, 2013 ) and more prominently platelet-primed HSCs (Sanjuan-Pla et al., 2013; Yamamoto et al., 2013) expand in aged mice (Grover et al., 2016) . However, both platelet-primed and unprimed old HSCs exhibit myeloid bias (Grover et al., 2016) , possibly suggesting a microenvironmental participation. The standard model of platelet generation (thrombopoiesis) suggests that megakaryocyte precursors migrate from endosteal BM (close to bone) to sinusoids (further from bone) for maturation (Eto and Kunishima, 2016) , which can be promoted by cytokines like interleukin (IL)-1a IL-1b, IL-6, IL-3, and interferon-gamma (IFNg) (Pietras, 2017) . Whereas platelet-biased HSCs are located near sinusoids (Pinho et al., 2018) , both megakaryocytes and their precursors have been recently found throughout BM, including the sinusoids where megakaryocyte maturation and thrombopoiesis take place (Plo et al., 2017; Stegner et al., 2017) . In this study, we have investi- gated whether different BM microenvironments regulate myeloid differentiation and megakaryopoiesis during aging.
RESULTS

Reduction of Endosteal Niches and Expansion of Non-endosteal Neurovascular Niches during Aging
To characterize changes in vascular beds during aging, we performed whole-mount immunofluorescence staining of thick femoral sections of young and old wild type (WT) mice using CD31 and endomucin (EMCN) to identify sinusoids, arterioles, capillaries, and transition zone vessels (TZVs), which connect arterioles with sinusoids near bone (endosteum). Consistent with previous findings (Kusumbe et al., 2016) , endosteal vessels and TZVs were reduced in old mice; however, we also noted that, whereas sinusoidal areas appeared unchanged, arterioles were slightly reduced and capillaries located further from bone increased 4-fold in old mice ( Figures 1A-1F ). These vascular changes were paralleled by similar alterations of their associated perivascular cells. We used Nes-gfp transgenic mice, which carry HSC niche-forming perivascular BM mesenchymal stem or progenitor cells (BMSCs) labeled with GFP (Mé ndez-Ferrer et al., 2010b) . Nes-GFP + cells augmented 4-fold specifically in non-endosteal BM, mostly associated with the increased capillaries ( Figures 1G-1I and S1A-S1D). These changes correlated with increased inflammatory cytokines that drive myeloid cell expansion (Pietras, 2017) . The concentration of IL-1a, IL-1b, and IL-6 increased in the BM during aging, whereas IL-3 and IFNg showed similar trends ( Figures 1J-1N and S1M-S1Q).
We have previously shown that sympathetic adrenergic signals regulate Nes-GFP + cell proliferation (Mé ndez-Ferrer et al., 2010b) and are affected during age-related myeloproliferative neoplasms . Additionally, increased sympathetic adrenergic activity has been previously described during aging (Hart and Charkoudian, 2014; Ng et al., 1993; Veith et al., 1986; Ziegler et al., 1976) , chronic stress, and depression (Yirmiya et al., 2006) , and might increase osteoporosis and fracture risk by restraining bone formation (Elefteriou et al., 2005; Takeda et al., 2002) . However, the opposite (decreased BM adrenergic innervation) has been recently suggested as causative of HSC aging (Maryanovich et al., 2018) . To clarify this, whole-mount preparations of skulls and thick tibial sections of Nes-gfp mice were immunostained for tyrosine hydroxylase (TH), to visualize sympathetic noradrenergic fibers and nestin + cells in large 3D volumes. This study did not confirm reduced TH + fibers in the aged BM (Maryanovich et al., 2018) but found these fibers increased by 50% in the skull of old mice (Figures 2A-2C ) and augmented 2.5-fold in the aged tibial BM, compared with the young samples ( Figures 2D-2F ). In both cases, nestin + cells were found in proximity of noradrenergic fibers (Figures S1E-S1L). Together, these results suggest contraction of endosteal (bone-associated) HSC niches and expansion of non-endosteal neurovascular HSC niches during aging. Figure 3N ), whereas other circulating blood cell types remained unaffected ( Figures S2G-S2J ). These results suggest that increased b-adrenergic signaling in the BM promotes myeloid differentiation into platelets during aging. Figure S3F ). (N) Circulating platelets in young (n = 11) and old (n = 6) WT mice, compared with young (n = 9) and old (n = 5) Adrb2
were analyzed between 8-30 weeks of age, and old mice were 66-120 weeks old. Data are means ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001 (one-way ANOVA followed by Bonferroni pairwise comparisons).
To test the potential significance of this regulation in the human setting, we treated human umbilical cord bloodderived hCD34 + HSPCs co-cultured with MS-5 cells with a selective b 2 -AR agonist ( Figure 4D ). Treatment with b 2 -AR agonist increased the frequency of human CD61 + megakaryocytic cells ( Figures 4E-4G ). These results suggest that b 2 -AR stimulation of stromal cells promotes megakaryocyte differentiation.
b 2 -AR Indirectly Promotes Megakaryocyte Differentiation through IL-6 To investigate the underlying mechanism, we measured several cytokines which regulate megakaryopoiesis. Among those, IL-6 concentration increased in WT BM during aging ( Figure 1H ) and was low in endosteal Adrb2 À/À BM (Figures 4H and S3G-S3I).
Moreover, b 2 -AR agonist increased Il6 mRNA 2-fold in MS-5 stromal cells; this effect was abrogated after blocking protein kinase A ( Figure 4I ) downstream of b 2 -AR signaling (Rosenbaum et al., 2009 Figure 4N ). Altogether, these results suggest that b 2 -AR on stromal cells promotes megakaryocyte differentiation through IL-6.
b 3 -AR-Deficient Mice Exhibit Altered HSC Lineage Bias Our co-culture experiments suggested that, contrasting b 2 -AR, b 3 -AR might inhibit megakaryocytic differentiation ( Figures  S3C-S3F ). Additionally, b 3 -AR stimulation has been shown to promote HSC lymphoid skewing (Maryanovich et al., 2018) . Therefore, we measured the frequency of immunophenotypically defined lymphoid-biased HSCs ( Figure S4A ; Yamamoto et al., 2013) . Lymphoid-biased HSCs were reduced by one-third in adult endosteal Adrb3 00 and S4B 00 ), implying niche-mediated regulation. Opposite trends were observed for long-term HSCs (LT-HSCs) and myeloid-biased HSCs, with their frequencies tending to increase in endosteal Adrb3 À/À BM ( Figures S4C-S4F ). These results suggest accelerated lymphoid deficiency in the endosteal microenvironment lacking b 3 -AR. We investigated possible mechanisms that might explain the intriguingly opposite effects of b 3 -AR and b 2 -AR signaling on lympho-myeloid lineage skewing. Whereas both b-ARs can activate G proteins (Rosenbaum et al., 2009) , their differential cardiovascular effects have been attributed to b 3 -AR-dependent nitric oxide (NO) generation (Gauthier et al., 1998) . Therefore, we measured nitrate concentration in the BM extracellular fluid and found it doubled in endosteal (compared with non-endosteal) WT BM and halved in Adrb3 À/À BM ( Figure 5B ). Among NO synthases, Nos1 (but not Nos2 or Nos3) showed higher mRNA expression in endosteal WT BM and was downregulated in Figures S4L-S4N ), contrasting previous findings (Maryanovich et al., 2018) . Whereas adult Adrb3 À/À mice did not yet show in our analysis premature hematopoietic aging in peripheral blood, adult Nos1 À/À mice showed reduced lymphocytes and increased neutrophils and platelets in circulation ( Figures 6A and 6B ), suggesting that other pathways (besides b 3 -AR) contribute to Nos1-dependent regulation of hematopoiesis. Altogether, these results suggest that microenvironmental b 3 -AR contributes to balance HSC lineagebias toward lymphoid production, which is at least partially dependent on Nos1-dependent NO production.
Premature Hematopoietic Aging in HGPS Is Not HSCAutonomous
We next interrogated whether the BM microenvironment might promote pathological (and not only physiological) hematopoietic aging. Premature aging in Hutchinson-Gilford progeria syndrome (HGPS) is caused by the accumulation of a truncated prelamin A protein named ''progerin,'' which is produced via aberrant splicing resulting from a de novo synonymous c.1824C > T (p.G608G) point mutation in the LMNA gene (encoding lamin A and C) (De Sandre-Giovannoli et al., 2003; Eriksson et al., 2003) . This gene has been recently associated with changes in epigenetic and chromatin architecture in aged HSCs (Grigoryan et al., 2018) . Progerin also accumulates during normal aging and HGPS displays most aging hallmarks, suggesting that HGPS can inform physiological aging . Lmna G609G knockin mice exhibit key hallmarks of the human disease, including accelerated aging, shortened lifespan, and bone and cardiovascular defects ( Hamczyk et al., 2018; Osorio et al., 2011; Villa-Bellosta et al., 2013) . Certain hallmarks of hematopoietic aging in mice, such as increased circulating platelets, have been observed in HGPS (Merideth et al., 2008) . However, it remains unknown whether premature aging affects the overall hematopoietic system in HGPS and whether this is a consequence of the LMNA mutation in HSCs, other hematopoietic cells and/or their microenvironment.
We measured peripheral blood counts in progeroid mice and control mice. Remarkably, adult progeroid mice resembled adult Nos1 À/À mice (Figures 6A and 6B) in their premature myeloid skewing evidenced by decreased lymphocytes and increased neutrophils, monocytes, and platelets ( Figures 6C and 6D) , to a similar extent as normally aged mice (Dykstra et al., 2011; Rossi et al., 2005; Sudo et al., 2000) . Flow cytometry analysis confirmed increased myeloid cells and decreased lymphoid cells in the peripheral blood of progeroid mice ( Figures 6E-6G) .
To test HSC function, lethally irradiated CD45.1 recipients were transplanted with CD45.2 BM cells from Lmna G609G/G609G mice or WT mice, together with competitor BM cells from congenic CD45.1 mice ( Figure S5A ). Long-term engraftment was lower for Lmna G609G/G609G (compared with WT) hematopoietic cells ( Figure S5B) Figures 6C and 6D) . Together, these results suggest that premature aging in HGPS affects the hematopoietic system but cannot be explained by HSC-autonomous alterations. Consistent with this idea, microenvironmental alterations (such as sinusoidal vasodilation) were found in Lmna G609G/G609G BM ( Figures S5D   and S5E ). Moreover, myelopoietic cytokines augmented in normally aged BM microenvironment ( Figures 1J-1N ) were also increased in adult progeroid mice ( Figures 6M-6Q ). These results suggested that similar microenvironmental alterations might promote myeloid differentiation during physiological/pathological aging. Therefore, we tested whether targeting the microenvironment could impact hematopoiesis in HGPS. Progeroid mice were chronically treated with a b 3 -AR agonist, which can rescue nestin + niches in humans and mice with agerelated myeloproliferative disorders Drexler et al., 2019) and has been recently suggested to rejuvenate normally aged HSCs (Maryanovich et al., 2018) . Treatment with b 3 -AR agonist over 2 months normalized circulating granulocytes and lymphocytes and BM neutrophils and partially rescued BM B cells ( Figures 7A-7D ). This effect correlated with decreased frequency of BM LT-HSCs ( Figures 7E and 7F) . Megakaryocytes have been shown to regulate HSC proliferation (Bruns et al., 2014; Nakamura-Ishizu et al., 2015; Zhao et al., 2014) and their numbers were found to increase during normal/ pathological aging in this study. Therefore, we examined the spatial relationships between megakaryocytes and HSPCs in the different models. Like in aged mice (Maryanovich et al., 2018) , HSCs expanded but located further from megakaryocytes in adult Adrb3 À/À mice, as an additional premature aging feature in these mice ( Figures S6A-S6D ). Increased LT-HSC frequency in vehicle-treated progeroid mice (compared with WT mice) ( Figures 7E and 7F ) correlated with reduced co-localization of HSPCs and megakaryocytes, which was rescued by b 3 -AR agonist ( Figures 7G-7J ). HSCs located more distantly from megakaryocytes in vehicle-treated progeroid mice (compared with WT mice) but this association was partially restored by b 3 -AR agonist ( Figures 7K-7N ). These results suggest the possibility that decreased interactions between megakaryocytes and HSCs might reversibly regulate hematopoiesis during aging.
DISCUSSION
This study suggests that alterations of the BM microenvironment during pathological/physiological aging change hematopoiesis. Remodeling of BM HSC niches (namely reduced endosteal niches and increased non-endosteal neurovascular niches) is associated with the overproduction of pro-inflammatory cytokines which drive excessive myelopoiesis in normal/premature aging. However, the latter can be improved by modulating the microenvironment. Together, these results expand previous findings on the microenvironmental contribution to hematopoietic aging to the role of different neurovascular beds in normal and pathological aging, and their potential therapeutic targeting. Stem cell aging compromises tissue turnover and regeneration, but the contribution of the aged stem cell niche remains incompletely understood . In the hematopoietic system, HSCs expand during aging but exhibit impaired self-renewal and lymphoid differentiation potential, favoring myeloid output (Liang et al., 2005; Mohrin et al., 2015; Pang et al., 2011; Rossi et al., 2005; Rundberg Nilsson et al., 2016; Sudo et al., 2000) . Moreover, myeloid malignancies are more frequent in the elderly, but whether changes in the aged HSCs and/or their microenvironment predispose to these malignancies has remained unclear. Although HSC aging was initially regarded as solely derived from intrinsic changes in HSCs (Chambers et al., 2007; Dykstra et al., 2011; Florian et al., 2013; Rossi et al., 2007) , several alterations in the BM microenvironment or in its interaction with HSCs have been proposed to promote hematopoietic aging (Ergen et al., 2012; Ju et al., 2007; Kö hler et al., 2009; Maryanovich et al., 2018) . Our study supports this contention by demonstrating that changes in the microenvironment contribute to physiological hematopoietic aging and pathological premature aging (HGPS). In both settings, the aged microenvironment promotes myeloid differentiation through similar cytokines, such as IL-1b and IL-6.
Progeroid mice exhibit several hallmarks of hematopoietic aging: expanded HSCs with reduced engraftment, lymphoid deficiency, and myeloid skewing toward platelets. However, chimeric mice carrying Lmna G609G/G609G hematopoietic cells in a WT environment do not reproduce the hematopoietic aging of progeroid mice. Together with the altered vasculature and increased concentration of myelopoietic cytokines in progeroid BM, these results strongly suggest that the BM microenvironment causes premature hematopoietic aging in HGPS. In fact, chronic treatment of progeroid mice with b 3 -AR agonist (targeting the microenvironment) reduces HSCs and restores their proximity to megakaryocytes and their lympho-myeloid skewing. During physiological aging, endosteal BM niches decrease, consistent with previous observations (Kusumbe et al., 2016) , whereas non-endosteal neurovascular BM niches containing Nes-GFP + stromal cells show a pronounced expansion. This microenvironmental remodeling might directly favor myeloid expansion during aging, because lymphoid niches have been found near bone (Morrison and Scadden, 2014) , whereas myeloid cell expansion and thrombopoiesis mainly occurs in non-endosteal niches (Eto and Kunishima, 2016) .
Recently, an age-related reduction of BM adrenergic nerve fibers has been reported to dive most hallmarks of HSC aging (Maryanovich et al., 2018) . However, studies on BM innervation during aging have provided conflicting results, with BM adrenergic fibers reportedly been dramatically reduced (Maryanovich et al., 2018) , unchanged, or increased (Chartier et al., 2018) . The whole-mount or thick section imaging and 3D reconstruction of different bones in the present study supports the latter and demonstrates that these fibers are doubled in different bones during physiological aging. Moreover, these fibers are not reduced in adult progeroid mice ( Figure S7 ), which exhibit premature hematopoietic aging. Our findings are consistent with the wellknown increase in sympathetic activity in the elderly (Hart and Charkoudian, 2014; Ng et al., 1993; Veith et al., 1986; Ziegler et al., 1976) and suggest a functional change of neurotransmission (b 2 -AR overriding b 3 -AR), rather than a general decline of BM innervation during aging. Actually, increased noradrenergic activity in the BM seems to account for augmented thrombopoiesis in aged mice because platelets are not elevated in aged Adrb2 À/À mice or Adrb2
showed direct effects of a-ARs on mature megakaryocyte adhesion, proplatelet formation, and platelet release, whereas a-AR signaling on more primitive CD34 + progenitor cells did not affect lineage commitment (Chen et al., 2016) . However, the present study indicates that HSPC lineage commitment is regulated by the microenvironment through b 2 -AR and b 3 -AR. Therefore, BM noradrenergic activity appears to regulate lineage commitment and megakaryopoiesis at different stages of maturation through distinct a-and b-ARs. Interestingly, b 2 -AR and b 3 -AR exhibit opposite roles on myeloid differentiation: whereas b 2 -AR signaling promotes megakaryopoiesis through stromalcell-derived IL6 and becomes predominant during aging, b 3 -AR inhibits myelopoiesis. Lack of b 2 -AR in the microenvironment (but not in the hematopoietic system) halves myeloid and megakaryocyte progenitors in adult mice. Figures 4B, 4C , and 5A), further suggesting that b 2 -AR prevails over b 3 -AR in hematopoietic lineage regulation during aging. This regulation requires IL-6, a cytokine known to increase in elderly humans (Brusnahan et al., 2010) and to be similarly regulated in other cell types (Li et al., 2013) . Supporting the role of IL6, megakaryocytes appear decreased in Il6 À/À BM.
Moreover, b 2 -AR agonist specifically increased IL-6 expression in stromal cells co-cultured with human/murine HSPCs and consequently stimulates megakaryopoiesis in these co-cultures or in primary BM cultures from WT mice, but not Il6 À/À mice.
In contrast, microenvironmental (but not hematopoietic) lack of b 3 -AR partially reduces lymphoid-biased HSCs in adult mice, as previously reported (Maryanovich et al., 2018) . However, the results here differ in that b 3 -AR loss does not appear overall sufficient to cause premature hematopoietic aging, because the frequencies of circulating lymphocytes and myeloid cells appeared unchanged in 5-month-old Adrb3 À/À mice.
In vitro, b 3 -AR agonist-treated stromal cells decrease human and murine HSPC differentiation into megakaryocytes. This effect requires Nos1, because Nos1 À/À mice have high circulating platelets and granulocytes, but low circulating lymphocytes. Furthermore, b 3 -AR agonist specifically increases lymphoidbiased HSCs in primary BM cultures in a Nos1-dependent manner. Moreover, adult Adrb3 À/À or Nos1 À/À mice share premature microenvironmental aging features in the BM, such as reduced bone-forming transition zone vessels (Kusumbe et al., 2016) and increased BM capillaries, myeloid progenitors, and megakaryocyte apposition to blood vessels. 
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METHODS DETAILS
Mouse strains Young mice were analyzed between 8-30 weeks of age, and old mice were 66-120 weeks old. Mice were housed in specific pathogen free facilities. All experiments using mice followed protocols approved by the Animal Welfare Ethical Committees, according to EU and United Kingdom Home Office regulations (PPL 70/8406). Nes-gfp (Mignone et al., 2004) , Adrb2 À/À (Chruscinski et al., 1999) , FVB/ N-Adrb3tm1Lowl/J (Susulic et al., 1995) , Lmnatm1.1Otin (Osorio et al., 2011 ), Vwf-egfp (Sanjuan-Pla et al., 2013 , B6.129S4-Nos1tm1Plh/J (stock#2986) (Huang et al., 1993) , B6.129S2-Il6tm1Kopf/J (stock#2650) (Kopf et al., 1994 ) (Jackson Laboratories) and congenic CD45.1 and CD45.2 C57BL/6 mice (Charles River Laboratories) were used in this study.
Mouse bone marrow transplantation and in vivo treatments
In Lmna G609G/G609G mouse model, HSC activity was assessed by long-term competitive repopulation assay using the congenic CD45.1/CD45.2 isotypes. Recipient female CD45.1 C57BL/6 mice (8 week-old) were subjected to lethal irradiation (12 Gy whole body irradiation, split dose 6.0 + 6.0 Gy, 3 h apart). 10 6 BM nucleated cells from (CD45.2) WT mice or LmnaG619G/G609G mice were mixed with 10 6 BM nucleated cells from CD45.1 C57BL/6 mice and i.v. transplanted in 200 mL sterile PBS into lethally irradiated CD45.1 C57BL/6 mice. At various time points after transplantation (4, 8, 12 and 16 weeks), peripheral blood nucleated cells were collected from recipients. Cells were stained with fluorescent-conjugated antibodies against B220, Mac1 and CD90 antigens, and analyzed by fluorescence-activated cell sorting. The selective b3-AR agonist BRL37344 (Sigma, St. Louis, MO) was administered at 2mg/kg through intraperitoneal (i.p.) injection once per day. Vehicle (saline solution) daily injections were performed in the same way. Treatment was initiated when Lmna G609G/G609G mice were 7 weeks old and lasted for 8 weeks. To generate chimeric mice carrying Adrb2 À/À or Adrb3 À/À BM cells, two-month-old C57BL/6 mice were lethally irradiated (12 Gy, two split doses) and i.v. transplanted with 2 X 10 6 nucleated BM cells from two-month-old WT, Adrb2 À/À or Adrb3 À/À mice. To test microenvironment-dependent effects of b-adrenergic signaling, WT, Adrb2 À/À or Adrb3 À/À (CD45.2) mice were lethally irradiated (12 Gy, two split doses) and i.v. transplanted with 2 X 10 6 nucleated BM cells from CD45.1 C57BL/6 mice. Hematopoietic cells in the BM were analyzed 4 months after transplantation in both settings.
BM cell extraction, flow cytometry and fluorescence-activated cell sorting For BM hematopoietic cell isolation, bones were crushed in a mortar, filtered through a 40-mm strainer to obtain single cell suspensions, and depleted of red blood cells by lysis in 0.15 M NH 4 Cl for 10 min at 4 C. Blood samples were directly lysed. Cells were incubated with the appropriate dilution (2-5 mg/ml) of fluorescent antibody conjugates and 4',6-diamidino-2-phenylindole (DAPI) for dead cell exclusion, and analyzed on LSRFortessa flow cytometer (BD Biosciences, Franklin Lakes, NJ) equipped with FACSDiva Software Measurement of nitrate concentration NO(X) content was measured in freshly-thawed samples that had been kept at À80 C for less than 2 months using a nitric oxide analyzer (NOA) 280i (Siever, GE Healthcare) according to the manufacturer's instructions. Data were collected, processed and analyzed by using liquid software (Siever, GE Healthcare).
Statistical analyses
Statistical analyses and graphics were carried out with GraphPad Prism 5 software and Microsoft Excel.
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